Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Ultrasound-Guided Long vs Short Peripheral IV Catheters in Neonates With Congenital Syphilis Receiving Antibiotics (ULTRA-ACCESS)

6. maj 2026 opdateret af: Hospital de Clinicas de Porto Alegre

Ultrasound-Guided Long Peripheral Intravenous Catheters Versus Conventional Short Peripheral Catheters for Reducing Post-Insertion Failure in Neonates With Congenital Syphilis Receiving Antibiotic Therapy: A Randomized Clinical Trial

Congenital syphilis in newborns requires intravenous antibiotic therapy, making reliable peripheral venous access essential. However, high rates of catheter failure and repeated punctures remain a significant clinical challenge. This randomized, controlled, parallel clinical trial aims to compare ultrasound-guided long peripheral intravenous catheters inserted by a specialized vascular access team with conventional short peripheral catheters inserted by neonatal nurses. A total of 104 newborns with congenital syphilis receiving intravenous penicillin will be randomly assigned to either group. The primary outcome is functional dwell time. Secondary outcomes include catheter failure, number of insertion attempts, first-attempt success, complications, and total number of devices required. The study hypothesizes that ultrasound-guided long peripheral catheters will improve vascular access outcomes, reduce complications, and minimize the need for repeated punctures.

Studieoversigt

Detaljeret beskrivelse

Congenital syphilis remains a significant public health problem and requires prolonged intravenous antibiotic therapy, typically with crystalline penicillin. In this context, reliable peripheral venous access is essential to ensure treatment continuity and safety. However, vascular access in newborns is particularly challenging due to small vessel caliber, tissue fragility, and increased susceptibility to complications, often resulting in high rates of catheter failure and repeated insertion attempts.

Short peripheral intravenous catheters inserted using conventional techniques are the most commonly used devices in neonatal care. Despite their widespread use, these devices are associated with limited dwell time and a higher likelihood of failure. Current guidelines recommend the use of adjunct technologies, such as ultrasound guidance, as well as devices with longer dwell times to improve vascular access outcomes. Ultrasound-guided insertion allows better visualization of vessels, potentially increasing first-attempt success and reducing complications. In addition, long peripheral intravenous catheters may provide greater stability and prolonged functional use compared with short catheters.

This study is a randomized, controlled, parallel, prospective clinical trial designed to compare ultrasound-guided long peripheral intravenous catheters inserted by a specialized vascular access team with conventional short peripheral catheters inserted by neonatal nurses. The study will be conducted in the Neonatal Intermediate Care Unit of the Hospital de Clínicas de Porto Alegre, Brazil, between May 2026 and March 2028.

Eligible participants are newborns diagnosed with congenital syphilis who require intravenous antibiotic therapy with crystalline penicillin for a planned duration of ten days. After enrollment, participants will be randomly assigned to either the intervention group (ultrasound-guided long peripheral intravenous catheter) or the control group (short peripheral catheter inserted using conventional technique).

The primary outcome is functional catheter dwell time, defined as the duration from catheter insertion to removal due to completion of therapy or occurrence of failure. Secondary outcomes include catheter failure, number of insertion attempts, first-attempt success, incidence of complications (such as infiltration, extravasation, obstruction, and phlebitis), and total number of devices required during treatment.

Data will be collected prospectively using standardized forms, and outcome assessment will be performed by trained personnel not directly involved in catheter insertion. Statistical analysis will follow the intention-to-treat principle, and results will be reported in accordance with CONSORT guidelines.

It is hypothesized that ultrasound-guided long peripheral intravenous catheters will result in longer functional dwell time, fewer failures, and reduced need for repeated punctures, contributing to improved vascular preservation, enhanced patient safety, reduced neonatal pain and stress, and more efficient use of healthcare resources.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

104

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Newborns admitted to the Neonatal Intermediate Care Unit;
  • Diagnosis of congenital syphilis;
  • Indication for intravenous penicillin therapy for an estimated duration of 10 days;
  • Enrollment on the first day of treatment.

Exclusion Criteria:

  • Newborns who have received any type of peripheral venous catheter prior to study enrollment;
  • Clinical instability at the time of vascular access indication and/or requirement for admission to a Neonatal Intensive Care Unit;
  • Requirement for concomitant administration of another antimicrobial agent in addition to crystalline penicillin;
  • Need for catheter insertion outside the operating hours of the Vascular Access Program (7:00 AM to 7:00 PM, Monday to Friday).

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Andet
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Intervention
Ultrasound-guided insertion of a long peripheral intravenous catheter performed by nurses from the Vascular Access Program.
Participants in the intervention group will undergo ultrasound-guided insertion of a long peripheral intravenous catheter, performed by nurses from the Vascular Access Program. A portable ultrasound system with a high-frequency linear transducer (6-13 MHz), suitable for visualization of superficial vessels in neonates, will be used. Long peripheral intravenous catheters available at the institution will be used, in sizes 24G (32 mm) and 22G (64 mm), composed of radiopaque polyurethane and indicated for ultrasound-guided insertion. Procedures will follow institutional protocols for ultrasound-guided peripheral venous access and device selection. A maximum of four insertion attempts per participant will be allowed, with up to two attempts performed by one professional and, if necessary, two additional attempts by another nurse from the Vascular Access Program.
Aktiv komparator: Control
Conventional insertion of a short peripheral intravenous catheter performed by bedside neonatal nurses.
Participants in the control group will undergo insertion of a short peripheral intravenous catheter using the conventional technique (visualization and palpation), performed by bedside nurses from the Neonatology Service. Short peripheral intravenous catheters available at the institution will be used, in sizes 24G (19 mm) and 22G (25 mm), composed of radiopaque polyurethane and intended for single-use peripheral venous access. Procedures will follow institutional protocols for conventional peripheral venous access and device selection. A maximum of four insertion attempts per participant will be allowed, with up to two attempts performed by one professional and, if necessary, two additional attempts by another bedside neonatal nurse.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Functional Catheter Dwell Time
Tidsramme: Up to 10 days
Time (in hours) from successful catheter insertion to device removal for any reason, excluding planned removal at completion of antibiotic therapy.
Up to 10 days

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Eneida R. Rabelo da Silva, ScD, Hospital de Clínicas de Porto Alegre

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. maj 2026

Primær færdiggørelse (Anslået)

1. marts 2028

Studieafslutning (Anslået)

1. december 2028

Datoer for studieregistrering

Først indsendt

28. april 2026

Først indsendt, der opfyldte QC-kriterier

28. april 2026

Først opslået (Faktiske)

5. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

11. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

6. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner